Dr. Nirav Y. Raval, MD
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
At a glance
- Medical school
- Northeastern Ohio University College of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2005
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Northeastern Ohio University College of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
FL license ME116401 -
Cardiovascular Disease Physician
FL license ME 116401 · GA license 054496
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- St Josephs Hospital Tampa, FL
- Morton Plant Hospital Clearwater, FL
Medical groups
- Baycare Medical Group, Inc. (1,547 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 216 | 38 |
| Established patient office or other outpatient visit, 40-54 minutes | 44 | 32 |
| Established patient office or other outpatient visit, 30-39 minutes | 39 | 32 |
| Critical care, first 30-74 minutes | 37 | 12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 32 | 29 |
| Biopsy of heart muscle | 21 | 18 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 19 | 19 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 17 | 14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tacrolimus Other prescribers in Tampa, FL | 26 |
| Jardiance (empagliflozin) Other prescribers in Tampa, FL | 14 |
| Rosuvastatin Calcium Other prescribers in Tampa, FL | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 75 payments worth $23,641 in total to this clinician.
| Cvrx, Inc. | $17,183 |
|---|---|
| Impulse Dynamics (USA) Inc. | $4,287 |
| Abiomed | $551 |
| Abbott Laboratories | $480 |
| Boston Scientific Corporation | $191 |
| Nuwellis, Inc. | $150 |
| Procyrion, Inc. | $141 |
| Medtronic, Inc. | $134 |
| Consulting Fee | $12,600 |
|---|---|
| Travel and Lodging | $4,119 |
| Food and Beverage | $3,922 |
| Honoraria | $3,000 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Cvrx, Inc. Aug 26, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $4,050 |
| Cvrx, Inc. Jun 16, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $2,700 |
| Cvrx, Inc. Nov 25, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $2,700 |
| Impulse Dynamics (USA) Inc. Apr 15, 2025 | Honoraria Optimizer; Optimizer · Cardiovascular Device | $1,500 |
| Impulse Dynamics (USA) Inc. Jun 12, 2025 | Honoraria Optimizer; Optimizer · Cardiovascular Device | $1,500 |
| Cvrx, Inc. Jul 30, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Washington, DC | $1,097 |
| Cvrx, Inc. Oct 27, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Washington, DC | $970 |
| Cvrx, Inc. Oct 1, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $900 |
| Cvrx, Inc. Oct 28, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $900 |
| Cvrx, Inc. Feb 6, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $700 |
All 20 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Impulse Dynamics (USA) Inc. Dec 13, 2025 | Travel and Lodging Optimizer; Optimizer · Cardiovascular Device · travel to Dallas, TX | $137 |
| Impulse Dynamics (USA) Inc. Dec 12, 2025 | Travel and Lodging Optimizer; Optimizer · Cardiovascular Device · travel to Dallas, TX | $328 |
| Impulse Dynamics (USA) Inc. Dec 12, 2025 | Travel and Lodging Optimizer; Optimizer · Cardiovascular Device · travel to Dallas, TX | $259 |
| Impulse Dynamics (USA) Inc. Dec 12, 2025 | Travel and Lodging Optimizer; Optimizer · Cardiovascular Device · travel to Dallas, TX | $130 |
| Cvrx, Inc. Nov 25, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $2,700 |
| Cvrx, Inc. Oct 28, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $900 |
| Cvrx, Inc. Oct 27, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Washington, DC | $970 |
| Cvrx, Inc. Oct 9, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $450 |
| Cvrx, Inc. Oct 1, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $900 |
| Cvrx, Inc. Sep 16, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $200 |
| Cvrx, Inc. Aug 26, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $4,050 |
| Cvrx, Inc. Jul 30, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Washington, DC | $1,097 |
| Cvrx, Inc. Jul 1, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Dallas, TX | $293 |
| Cvrx, Inc. Jun 16, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $2,700 |
| Impulse Dynamics (USA) Inc. Jun 12, 2025 | Honoraria Optimizer; Optimizer · Cardiovascular Device | $1,500 |
| Cvrx, Inc. Jun 12, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Tulsa, OK | $365 |
| Cvrx, Inc. Jun 12, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Arlington, VA | $34.00 |
| Impulse Dynamics (USA) Inc. Apr 15, 2025 | Honoraria Optimizer; Optimizer · Cardiovascular Device | $1,500 |
| Cvrx, Inc. Feb 6, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $700 |
| Cvrx, Inc. Feb 5, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Miami Beach, FL | $507 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $112,019 in research payments for these studies, mostly to the institutions running them.
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion, Inc. · Recruiting · NCT05677100 - Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics (USA) Inc. · Recruiting · NCT05064709
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.